Clinical Trial Update: Bioequivalence of the Tablet and Liquid-Filled Capsule Forms of MK0974 (0974-042) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the bioequivalence of tablet and liquid-filled capsule forms of MK0974 in migraine; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• MK0974

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Migraine | Phase 1 | Status: COMPLETED